<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="case-report"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Arch Iran Med</journal-id><journal-id journal-id-type="iso-abbrev">Arch Iran Med</journal-id><journal-id journal-id-type="publisher-id">Arch Iran Med</journal-id><journal-id journal-id-type="publisher-id">AIM</journal-id><journal-title-group><journal-title>Archives of Iranian Medicine</journal-title></journal-title-group><issn pub-type="ppub">1029-2977</issn><issn pub-type="epub">1735-3947</issn><issn-l>1029-2977</issn-l><publisher><publisher-name>Academy of Medical Sciences of I.R. Iran</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40001331</article-id><article-id pub-id-type="pmc">PMC11862395</article-id><article-id pub-id-type="doi">10.34172/aim.31746</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>A Novel Candidate Gene <italic toggle="yes">MACF1</italic> is Associated with Autosomal Dominant Non-syndromic Hearing Loss in an Iranian Family</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5455-272X</contrib-id><name><surname>Bazazzadegan</surname><given-names>Niloofar</given-names></name><role content-type="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="https://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="https://credit.niso.org/contributor-roles/software/">Software</role><role content-type="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="https://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="A01" ref-type="aff">
<sup>1</sup>
</xref><xref rid="COR1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2532-4303</contrib-id><name><surname>Babanejad</surname><given-names>Mojgan</given-names></name><role content-type="https://credit.niso.org/contributor-roles/software/">Software</role><xref rid="A01" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Banihashemi</surname><given-names>Susan</given-names></name><role content-type="https://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="A01" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Arzhangi</surname><given-names>Sanaz</given-names></name><role content-type="https://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="A01" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6587-7706</contrib-id><name><surname>Kahrizi</surname><given-names>Kimia</given-names></name><role content-type="https://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="A01" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3061-3652</contrib-id><name><surname>Booth</surname><given-names>Kevin TA</given-names></name><role content-type="https://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="A02" ref-type="aff">
<sup>2</sup>
</xref><xref rid="A03" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6084-7778</contrib-id><name><surname>Najmabadi</surname><given-names>Hossein</given-names></name><role content-type="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="https://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="A01" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="A01">
<sup>1</sup>Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran</aff><aff id="A02">
<sup>2</sup>Department of Medical and Molecular Genetics, Indiana School of Medicine, Indianapolis, IN, USA</aff><aff id="A03">
<sup>3</sup>Department of Otolaryngology-Head and Neck Surgery, Indiana School of Medicine, Indianapolis, IN, USA</aff><author-notes><corresp id="COR1">
<label>*</label><bold>Corresponding Author:</bold> Niloofar Bazazzadegan, Email: <email>bazazzadeganniloofar@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>1</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>01</day><month>1</month><year>2025</year></pub-date><volume>28</volume><issue>1</issue><fpage>63</fpage><lpage>66</lpage><history><date date-type="received"><day>20</day><month>7</month><year>2024</year></date><date date-type="accepted"><day>12</day><month>10</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2025 The Author(s).</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="https://journalaim.com">https://journalaim.com</self-uri><abstract><p>Cytoskeletal dynamics, the interplay of actin, microtubules, and septins, is a highly coordinated and tightly regulated process. Defects in the proteins involved can result in a wide range of cellular consequences. Hearing loss is the most common sensory defect and exhibits extraordinary genetic and phenotypic heterogeneity. Currently, there are more than 170 genes casually linked to non-syndromic hearing loss (NSHL), of which more than 60 are associated with autosomal dominant inheritance. Here, we add to this growing number by implicating <italic toggle="yes">MACF1</italic> (OMIM # 608271), as a novel candidate gene for autosomal dominant non-syndromic hearing loss (ADNSHL). MACF1&#x02019;s cytoskeleton integrator function and hair cell expression pattern lead one to believe that it is a necessary protein for hair cells. Many protein domains in MACF1 allow for dynamic interaction with the cytoskeleton. A large Iranian family segregating progressive ADNSHL was recruited for this study. The proband had bilateral mild-moderate sensorineural hearing loss and was negative for <italic toggle="yes">GJB2</italic> mutations. After applying exome sequencing on the proband, a missense mutation c.1378C&#x0003e;T (p.His460Tyr) was found in <italic toggle="yes">MACF1</italic> and co-segregated with the hearing loss in the extended family. We speculated that <italic toggle="yes">MACF1</italic> mutations probably cause non-syndromic hearing loss inherited in an autosomal dominant manner. The potential functional impact of the identified variant will be investigated through further analysis.</p></abstract><kwd-group><kwd>Autosomal dominant non-syndromic hearing loss</kwd><kwd>Iran</kwd><kwd>MACF1</kwd><kwd>Novel gene</kwd></kwd-group></article-meta><notes><p>
<bold>Cite this article as:</bold> Bazazzadegan N, Babanejad M, Banihashemi S, Arzhangi S, Kahrizi K, Booth KTA, et al. A novel candidate gene <italic toggle="yes">MACF1</italic> associated with autosomal dominant non-syndromic hearing loss in an Iranian family. Arch Iran Med. 2025;28(1):63-66. doi: 10.34172/aim.31746</p></notes></front><body><sec sec-type="introduction" id="s1"><title>Introduction</title><p> Congenital sensorineural hearing loss (HL) affects ~1 of every 1000 live births.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> This rises to 2.8 per 1000 in school-age children and to 3.5 per 1000 adolescents.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> In developed countries, it is estimated that ~80% of HL has a genetic etiology. After clinical evaluation, comprehensive genetic testing is the next best test to determine clinical actions and interventions, and to provide a definitive diagnosis. This allows for identification of the underlying genetic cause, facilitating tailored management strategies, genetic counseling, and prognosis determination.</p><p> Genetic HL displays a vast genetic allelic and phenotypic spectrum.<sup><xref rid="R3" ref-type="bibr">3</xref></sup> Currently, comprehensive genetic testing for HL returns positive results from a 35%&#x02012;50% diagnostic rate, depending on several variables such as: phenotype, onset, inheritance pattern, and ethnicity. This diagnostic rate illustrates the complexity of providing a genetic diagnosis, and implicates the contributions of novel genes to genetic HL that have yet to be identified.<sup><xref rid="R4" ref-type="bibr">4</xref></sup></p><p> Currently, there are more than 170 genes casually linked to non-syndromic hearing loss (NSHL), of which more than 60 are associated with autosomal dominant inheritance (AD) (org <uri xlink:href="https://hereditaryhearingloss.org/">https://hereditaryhearingloss.org/</uri>). Here, we add to this list by implicating <italic toggle="yes">MACF1</italic> as a possible novel gene for postlingual progressive ADNSHL.</p></sec><sec sec-type="case report" id="s2"><title>Case Report</title><p> The proband presented to the genetics clinic at University of Social Welfare and Rehabilitation Sciences. The proband has an extensive family history of HL (<xref rid="F1" ref-type="fig">Figure 1</xref>), accompanied by no other phenotypic manifestations. After obtaining informed consent, whole blood samples were collected from participating members and genomic DNA was extracted (<xref rid="F1" ref-type="fig">Figure 1</xref>). Affected members of the family underwent clinical re-evaluation to rule out potential missed syndromic forms of HL. Pure tone audiometry was performed on affected individuals and revealed a mild sloping to severe HL. The HL is described as postlingual, and progressive. Individual III.3 showed a more severe HL in the low frequencies and may represent some progression of the low frequencies with age. Initially, the proband underwent <italic toggle="yes">GJB2</italic> testing, which revealed no causal mutations. Subsequently, the proband underwent exome sequencing (ES) to determine the genetic cause of HL segregating in the family. After read mapping and quality filtering, the exome data was analyzed using a tiered approach. First, variants in genes causally linked to HL were reviewed and no plausible variant was identified, for either AD or autosomal recessive NSHL. Next, a broader search was employed. Variants were filtered based on minor allele frequency [ESP6500 (<uri xlink:href="http://evs.gs.washington.edu/EVS">http://evs.gs.washington.edu/EVS</uri>), ExAC (<uri xlink:href="https://exac.broadinstitute.org/">https://exac.broadinstitute.org/</uri>), Iranome (<uri xlink:href="http://www.iranome.ir/">http://www.iranome.ir/</uri>), and gnomAD (<uri xlink:href="http://gnomad.broadinstitute.org/">http://gnomad.broadinstitute.org/</uri>)], inheritance pattern and predicted variant consequence. Next, variants were prioritize based on <italic toggle="yes">in-silico</italic> predictions [PolyPhen2 (<uri xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</uri>), GERP&#x02005;+&#x02005;+&#x02005;, SIFT (<uri xlink:href="http://sift-dna.org">http://sift-dna.org</uri>) and PhyloP) and classifications in public databases [OMIM (<uri xlink:href="https://www.omim.org/">https://www.omim.org/</uri>) and ClinVar (<uri xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/">https://www.ncbi.nlm.nih.gov/clinvar/</uri>)] (<xref rid="F2" ref-type="fig">Figure 2</xref>) (<xref rid="Suppl1" ref-type="supplementary-material">Supplementary file 1</xref>, Table S1).</p><fig position="float" id="F1"><label>Figure 1</label><graphic xlink:href="aim-28-63-g001" position="float"/><statement><p>
Family Pedigree with Genotype of Affected and Normal Individuals (Affected individual has been shown with C/T genotype and normal individual with C/C). Pure tone audiometry for right and left ears of proband, proband&#x02019;s father and daughter</p></statement></fig><fig position="float" id="F2"><label>Figure 2</label><graphic xlink:href="aim-28-63-g002" position="float"/><statement><p>
Variant Filtering and Prioritization Based on <italic toggle="yes">In-Silico</italic> Predictions (PolyPhen2, GERP++, SIFT, and PhyloP)</p></statement></fig><p> After applying the filtering above, four variants were further prioritized for segregation within the extended family. Of these, only the heterozygote missense variant (GRCh37/hg19ch:1, 39751285, NM_012090.5, c.1378C&#x02005;&#x0003e;&#x02005;T; p.His460Tyr) in <italic toggle="yes">MACF1</italic> co-segregated with the HL phenotype (<xref rid="T1" ref-type="table">Table 1</xref>; Figure S1). Forward primer: 5&#x02019;-AGACTTCTTGGCTCCCTCTG-3&#x02019; and reverse primer: 5&#x02019;-GAGTCCCTTGTTCCTCACCT-3&#x02019; were used for Sanger sequencing of the detected variant. This variant has a minor allele frequency (MAF) 0.000004 (GnomAD_exomes) and 0.000008 (ExAC). It has not been reported in Iranome which is a domestic population database.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><title>Databases and <italic toggle="yes">In Silico</italic> Algorithms for <italic toggle="yes">MACF1</italic> and Three Other Candidate Variants Undergoing Segregation Analysis
</title></caption><table frame="hsides" rules="none"><tbody><tr><td style="text-align:left;vertical-align:middle;border-width:0.5pt 0pt 0.5pt 0pt;border-style: solid none solid none;" rowspan="1" colspan="1">
<bold>Gene</bold>
</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0.5pt 0pt;border-style: solid none solid none;" rowspan="1" colspan="1">
<bold>Variant</bold>
</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0.5pt 0pt;border-style: solid none solid none;" rowspan="1" colspan="1">
<bold>CADD</bold>
</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0.5pt 0pt;border-style: solid none solid none;" rowspan="1" colspan="1">
<bold>GERP</bold>
</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0.5pt 0pt;border-style: solid none solid none;" rowspan="1" colspan="1">
<bold>SIFT</bold>
</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0.5pt 0pt;border-style: solid none solid none;" rowspan="1" colspan="1">
<bold>Phylop</bold>
</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0.5pt 0pt;border-style: solid none solid none;" rowspan="1" colspan="1">
<bold>Polyphen</bold>
</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0.5pt 0pt;border-style: solid none solid none;" rowspan="1" colspan="1">
<bold>Franklin</bold>
</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0.5pt 0pt;border-style: solid none solid none;" rowspan="1" colspan="1">
<bold>InterVar</bold>
</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0.5pt 0pt;border-style: solid none solid none;" rowspan="1" colspan="1">
<bold>Clinvar</bold>
</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0.5pt 0pt;border-style: solid none solid none;" rowspan="1" colspan="1">
<bold>MIM#</bold>
</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0.5pt 0pt;border-style: solid none solid none;" rowspan="1" colspan="1">
<bold>Segregation</bold>
</td></tr><tr style="background-color:#e3e8e1"><td style="text-align:left;vertical-align:middle;border-width:0.5pt 0pt 0pt 0pt;border-style: solid none none none;" rowspan="1" colspan="1">
<italic toggle="yes">MACF1</italic>
</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0pt 0pt;border-style: solid none none none;" rowspan="1" colspan="1">c.1378C&#x02005;&#x0003e;&#x02005;T</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0pt 0pt;border-style: solid none none none;" rowspan="1" colspan="1">23.3</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0pt 0pt;border-style: solid none none none;" rowspan="1" colspan="1">5.93</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0pt 0pt;border-style: solid none none none;" rowspan="1" colspan="1">0.003</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0pt 0pt;border-style: solid none none none;" rowspan="1" colspan="1">3.72</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0pt 0pt;border-style: solid none none none;" rowspan="1" colspan="1">&#x02014;</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0pt 0pt;border-style: solid none none none;" rowspan="1" colspan="1">VUS</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0pt 0pt;border-style: solid none none none;" rowspan="1" colspan="1">Likely pathogenic</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0pt 0pt;border-style: solid none none none;" rowspan="1" colspan="1">&#x02014;</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0pt 0pt;border-style: solid none none none;" rowspan="1" colspan="1">608271</td><td style="text-align:center;vertical-align:middle;border-width:0.5pt 0pt 0pt 0pt;border-style: solid none none none;" rowspan="1" colspan="1">Yes</td></tr><tr><td style="text-align:left;vertical-align:middle;" rowspan="1" colspan="1">
<italic toggle="yes">DNAH14</italic>
</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">c.1990-1991insTT</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">&#x02014;</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">&#x02014;</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">&#x02014;</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">&#x02014;</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">&#x02014;</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">Likely pathogenic</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">&#x02014;</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">&#x02014;</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">603341</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">No</td></tr><tr style="background-color:#e3e8e1"><td style="text-align:left;vertical-align:middle;" rowspan="1" colspan="1">
<italic toggle="yes">USP6</italic>
</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">c.G2763A</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">38</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">2.91</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">&#x02014;</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">9.74</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">&#x02014;</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">VUS</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">VUS</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">&#x02014;</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">604334</td><td style="text-align:center;vertical-align:middle;" rowspan="1" colspan="1">No</td></tr><tr><td style="text-align:left;vertical-align:middle;border-width:0pt 0pt 0.5pt 0pt;border-style: none none solid none;" rowspan="1" colspan="1">
<italic toggle="yes">MUC16</italic>
</td><td style="text-align:center;vertical-align:middle;border-width:0pt 0pt 0.5pt 0pt;border-style: none none solid none;" rowspan="1" colspan="1">c.40674-40677del</td><td style="text-align:center;vertical-align:middle;border-width:0pt 0pt 0.5pt 0pt;border-style: none none solid none;" rowspan="1" colspan="1">&#x02014;</td><td style="text-align:center;vertical-align:middle;border-width:0pt 0pt 0.5pt 0pt;border-style: none none solid none;" rowspan="1" colspan="1">&#x02014;</td><td style="text-align:center;vertical-align:middle;border-width:0pt 0pt 0.5pt 0pt;border-style: none none solid none;" rowspan="1" colspan="1">&#x02014;</td><td style="text-align:center;vertical-align:middle;border-width:0pt 0pt 0.5pt 0pt;border-style: none none solid none;" rowspan="1" colspan="1">&#x02014;</td><td style="text-align:center;vertical-align:middle;border-width:0pt 0pt 0.5pt 0pt;border-style: none none solid none;" rowspan="1" colspan="1">&#x02014;</td><td style="text-align:center;vertical-align:middle;border-width:0pt 0pt 0.5pt 0pt;border-style: none none solid none;" rowspan="1" colspan="1">VUS</td><td style="text-align:center;vertical-align:middle;border-width:0pt 0pt 0.5pt 0pt;border-style: none none solid none;" rowspan="1" colspan="1">&#x02014;</td><td style="text-align:center;vertical-align:middle;border-width:0pt 0pt 0.5pt 0pt;border-style: none none solid none;" rowspan="1" colspan="1">&#x02014;</td><td style="text-align:center;vertical-align:middle;border-width:0pt 0pt 0.5pt 0pt;border-style: none none solid none;" rowspan="1" colspan="1">606154</td><td style="text-align:center;vertical-align:middle;border-width:0pt 0pt 0.5pt 0pt;border-style: none none solid none;" rowspan="1" colspan="1">No</td></tr></tbody></table></table-wrap><p> The histidine in position 460 was changed with tyrosine which is an aromatic amino acid. According to HOPE results (<uri xlink:href="https://www3.cmbi.umcn.nl/hope/method/">https://www3.cmbi.umcn.nl/hope/method/</uri>), the wild-type and mutant amino acids differ in size. The mutant residue is bigger which might lead to local misfolding. The hydrophobicity of the wild-type and mutant residue differs. The mutation introduces a more hydrophobic residue at this position. This can result in loss of hydrogen bonds and/or disturb correct folding.</p></sec><sec sec-type="discussion" id="s3"><title>Discussion</title><p>On human Chr 1p32, the <italic toggle="yes">MACF1</italic> gene is located near the DFNA2 dominant HL locus. It has been demonstrated that HL in certain DFNA2 families is caused by mutations in <italic toggle="yes">KCNQ4</italic>, which are centromeric to <italic toggle="yes">MACF1.</italic><sup><xref rid="R5" ref-type="bibr">5</xref>-<xref rid="R7" ref-type="bibr">7</xref></sup> No plausible variants in <italic toggle="yes">KCNQ4</italic> were detected in the proband based on ES analysis. The microtubule and actin crosslinking factor 1 (<italic toggle="yes">MACF1</italic>) gene encodes Actin Crosslinking Family Protein 7 (MACF1), a massive (~500 kDa) cytoskeletal crosslinking protein that interacts with F-actin and microtubules to shape cell morphology.<sup><xref rid="R6" ref-type="bibr">6</xref></sup> Metazoan tissues have widespread expression of MACF1, indicating a notable degree of evolutionary conservation.<sup><xref rid="R8" ref-type="bibr">8</xref></sup> MACF1&#x02019;s cytoskeleton integrator function and hair cell expression pattern lead one to believe that it is a necessary protein for hair cells. The developmentally significant nature of microtubule and actin crosslinking factor 1 genes is established by the embryonic lethality of a null mutation in the mouse ortholog.<sup><xref rid="R9" ref-type="bibr">9</xref></sup> Moreover, a mutation in zebrafish causes abnormalities in the oocyte and egg&#x02019;s animal-vegetal polarity.<sup><xref rid="R10" ref-type="bibr">10</xref></sup> Many protein domains in MACF1 allow for dynamic interaction with the cytoskeleton. Direct contact between calponin homology 1 and 2 domains and F-actin is facilitated towards the N terminus. The GSR (Gly-Ser-Arg)-repeat domain, which also interacts with microtubules, the EF hand domains, which bind calcium, and the GAS2-related protein domain, which binds with microtubules and helps microtubule stabilization, are located close to the C-terminus.<sup><xref rid="R9" ref-type="bibr">9</xref></sup></p><p>Interestingly, although highly expressed, MACF1 is not required for normal hair cell development and maturation, and conditional knockout cKO mice for MACF1 have normal hearing at P30.<sup><xref rid="R11" ref-type="bibr">11</xref></sup> We speculate two possibilities to explain the phenotype seen in humans but not the cKO mouse. First, it is possible that MACF1 is dispensable for normal hair cell development and maturation but might play a more important role throughout the life of the hair cell, and examination of its absences at P30 might not capture its true biological role. Second, we identified a missense variant which is hypothesized to act as a gain-of-function or dominant negative and the cKO mouse is not a good model to recapitulate this effect. It is noteworthy that <italic toggle="yes">MACF1</italic> lies ~1.2 Mb downstream of <italic toggle="yes">KCNQ4&#x000ad;, </italic>andno plausible variants were detected in the exonic regions of <italic toggle="yes">KNCQ4</italic>.</p><p>Currently, variants in <italic toggle="yes">MACF1</italic> are causally linked to <ext-link xlink:href="https://www.uniprot.org/diseases/DI-05481" ext-link-type="uri">Lissencephaly 9 with complex brainstem malformation (LIS9)</ext-link>. LIS9 is an autosomal dominant form of lissencephaly, which is a disorder that affects the development of the brain&#x02019;s cortex. This disorder is characterized by the absence or thickening of the normal six-layered cortex, leading to disorganization. Clinically, LIS9 is associated with global developmental delay that is noticeable from infancy. Individuals with LIS9 also experience impaired intellectual development, often resulting in poor or absent speech. Additionally, abnormal or involuntary movements may be present. Brain imaging reveals malformation of the brainstem, as well as the presence of pachygyria and lissencephaly (MIM:<ext-link xlink:href="https://www.omim.org/entry/618325" ext-link-type="uri">618325</ext-link>). As it was obvious in our family, no syndrome was detected and only HL was found in the affected individuals.</p></sec><sec sec-type="conclusion" id="s4"><title>Conclusion</title><p> In conclusion, we report a novel candidate gene (<italic toggle="yes">MACF1</italic>) for autosomal dominant non-syndromic hearing loss (ADNSHL). Functional studies are needed to understand the impact of the p.His460Tyr variant on MACF1 function and how this variant results in HL. Additionally, identifying more families segregating NSHL and variants in <italic toggle="yes">MACF1</italic> will help provide a better understanding of MACF1 phenotypic spectrum. Finally, we have expended the phenotypic spectrum of MACF1 to include ADNSHL.</p></sec><sec sec-type="supplementary-material" id="Suppl"><title>Supplementary Files
</title><supplementary-material id="Suppl1" position="float" content-type="local-data"><caption><p>Supplementary file 1 contains Figure S1 and Table S1.
</p></caption><media xlink:href="aim-28-63-s001.pdf"/></supplementary-material></sec></body><back><ack><p> We express our gratitude to the patients&#x02019; family who took part in this research.</p></ack><fn-group><fn id="n1" fn-type="COI-statement"><p>
<bold>Competing Interests</bold>
</p><p> No conflicts of interest are disclosed by the authors.</p></fn><fn id="n2" fn-type="other"><p>
<bold>Ethical Approval</bold>
</p><p> We certify that every author complied with ethical guidelines and had no conflicting interests while doing this research. Consent forms were acquired, and the study was given ethical permission (Institutional ethical approval number: IR.USWR.REC.1401.198).</p></fn><fn id="n3" fn-type="financial-disclosure"><p>
<bold>Funding</bold>
</p><p> This study was supported by the Genetics Research Center, University of Social Welfare and Rehabilitation Sciences Tehran, Iran.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Korver</surname><given-names>AM</given-names></name>
<name><surname>Smith</surname><given-names>RJ</given-names></name>
<name><surname>Van Camp</surname><given-names>G</given-names></name>
<name><surname>Schleiss</surname><given-names>MR</given-names></name>
<name><surname>Bitner-Glindzicz</surname><given-names>MA</given-names></name>
<name><surname>Lustig</surname><given-names>LR</given-names></name>
<etal/>
</person-group><article-title>Congenital hearing loss</article-title><source>Nat Rev Dis Primers</source><year>2017</year><volume>3</volume><fpage>16094</fpage><pub-id pub-id-type="doi">10.1038/nrdp.2016.94</pub-id><pub-id pub-id-type="pmid">28079113</pub-id>
</element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ald&#x000e8;</surname><given-names>M</given-names></name>
<name><surname>Cantarella</surname><given-names>G</given-names></name>
<name><surname>Zanetti</surname><given-names>D</given-names></name>
<name><surname>Pignataro</surname><given-names>L</given-names></name>
<name><surname>La Mantia</surname><given-names>I</given-names></name>
<name><surname>Maiolino</surname><given-names>L</given-names></name>
<etal/>
</person-group><article-title>Autosomal dominant non-syndromic hearing loss (DFNA): a comprehensive narrative review</article-title><source>Biomedicines</source><year>2023</year><volume>11</volume><issue>6</issue><fpage>1616</fpage><pub-id pub-id-type="doi">10.3390/biomedicines11061616</pub-id><pub-id pub-id-type="pmid">37371710</pub-id>
</element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ali</surname><given-names>A</given-names></name>
<name><surname>Tabouni</surname><given-names>M</given-names></name>
<name><surname>Kizhakkedath</surname><given-names>P</given-names></name>
<name><surname>Baydoun</surname><given-names>I</given-names></name>
<name><surname>Allam</surname><given-names>M</given-names></name>
<name><surname>John</surname><given-names>A</given-names></name>
<etal/>
</person-group><article-title>Spectrum of genetic variants in bilateral sensorineural hearing loss</article-title><source>Front Genet</source><year>2024</year><volume>15</volume><fpage>1314535</fpage><pub-id pub-id-type="doi">10.3389/fgene.2024.1314535</pub-id><pub-id pub-id-type="pmid">38410152</pub-id>
</element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sloan-Heggen</surname><given-names>CM</given-names></name>
<name><surname>Bierer</surname><given-names>AO</given-names></name>
<name><surname>Shearer</surname><given-names>AE</given-names></name>
<name><surname>Kolbe</surname><given-names>DL</given-names></name>
<name><surname>Nishimura</surname><given-names>CJ</given-names></name>
<name><surname>Frees</surname><given-names>KL</given-names></name>
<etal/>
</person-group><article-title>Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing loss</article-title><source>Hum Genet</source><year>2016</year><volume>135</volume><issue>4</issue><fpage>441</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1007/s00439-016-1648-8</pub-id><pub-id pub-id-type="pmid">26969326</pub-id>
</element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gong</surname><given-names>TW</given-names></name>
<name><surname>Besirli</surname><given-names>CG</given-names></name>
<name><surname>Lomax</surname><given-names>MI</given-names></name>
</person-group><article-title>MACF1 gene structure: a hybrid of plectin and dystrophin</article-title><source>Mamm Genome</source><year>2001</year><volume>12</volume><issue>11</issue><fpage>852</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1007/s00335-001-3037-3</pub-id><pub-id pub-id-type="pmid">11845288</pub-id>
</element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Coucke</surname><given-names>PJ</given-names></name>
<name><surname>Van Hauwe</surname><given-names>P</given-names></name>
<name><surname>Kelley</surname><given-names>PM</given-names></name>
<name><surname>Kunst</surname><given-names>H</given-names></name>
<name><surname>Schatteman</surname><given-names>I</given-names></name>
<name><surname>Van Velzen</surname><given-names>D</given-names></name>
<etal/>
</person-group><article-title>Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families</article-title><source>Hum Mol Genet</source><year>1999</year><volume>8</volume><issue>7</issue><fpage>1321</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1093/hmg/8.7.1321</pub-id><pub-id pub-id-type="pmid">10369879</pub-id>
</element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xia</surname><given-names>JH</given-names></name>
<name><surname>Liu</surname><given-names>CY</given-names></name>
<name><surname>Tang</surname><given-names>BS</given-names></name>
<name><surname>Pan</surname><given-names>Q</given-names></name>
<name><surname>Huang</surname><given-names>L</given-names></name>
<name><surname>Dai</surname><given-names>HP</given-names></name>
<etal/>
</person-group><article-title>Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominant hearing impairment</article-title><source>Nat Genet</source><year>1998</year><volume>20</volume><issue>4</issue><fpage>370</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1038/3845</pub-id><pub-id pub-id-type="pmid">9843210</pub-id>
</element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kubisch</surname><given-names>C</given-names></name>
<name><surname>Schroeder</surname><given-names>BC</given-names></name>
<name><surname>Friedrich</surname><given-names>T</given-names></name>
<name><surname>L&#x000fc;tjohann</surname><given-names>B</given-names></name>
<name><surname>El-Amraoui</surname><given-names>A</given-names></name>
<name><surname>Marlin</surname><given-names>S</given-names></name>
<etal/>
</person-group><article-title>KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness</article-title><source>Cell</source><year>1999</year><volume>96</volume><issue>3</issue><fpage>437</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)80556-5</pub-id><pub-id pub-id-type="pmid">10025409</pub-id>
</element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kodama</surname><given-names>A</given-names></name>
<name><surname>Karakesisoglou</surname><given-names>I</given-names></name>
<name><surname>Wong</surname><given-names>E</given-names></name>
<name><surname>Vaezi</surname><given-names>A</given-names></name>
<name><surname>Fuchs</surname><given-names>E</given-names></name>
</person-group><article-title>ACF7: an essential integrator of microtubule dynamics</article-title><source>Cell</source><year>2003</year><volume>115</volume><issue>3</issue><fpage>343</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(03)00813-4</pub-id><pub-id pub-id-type="pmid">14636561</pub-id>
</element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gupta</surname><given-names>T</given-names></name>
<name><surname>Marlow</surname><given-names>FL</given-names></name>
<name><surname>Ferriola</surname><given-names>D</given-names></name>
<name><surname>Mackiewicz</surname><given-names>K</given-names></name>
<name><surname>Dapprich</surname><given-names>J</given-names></name>
<name><surname>Monos</surname><given-names>D</given-names></name>
<etal/>
</person-group><article-title>Microtubule actin crosslinking factor 1 regulates the Balbiani body and animal-vegetal polarity of the zebrafish oocyte</article-title><source>PLoS Genet</source><year>2010</year><volume>6</volume><issue>8</issue><fpage>e1001073</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.1001073</pub-id><pub-id pub-id-type="pmid">20808893</pub-id>
</element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gilbert</surname><given-names>BL</given-names></name>
<name><surname>Zhu</surname><given-names>S</given-names></name>
<name><surname>Salameh</surname><given-names>A</given-names></name>
<name><surname>Sun</surname><given-names>S</given-names></name>
<name><surname>Alagramam</surname><given-names>KN</given-names></name>
<name><surname>McDermott BM</surname><given-names>Jr</given-names></name>
</person-group><article-title>Actin crosslinking family protein 7 deficiency does not impair hearing in young mice</article-title><source>Front Cell Dev Biol</source><year>2021</year><volume>9</volume><fpage>709442</fpage><pub-id pub-id-type="doi">10.3389/fcell.2021.709442</pub-id><pub-id pub-id-type="pmid">34917607</pub-id>
</element-citation></ref></ref-list></back></article>